<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04142047</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00197581</org_study_id>
    <secondary_id>R01AG063661</secondary_id>
    <nct_id>NCT04142047</nct_id>
  </id_info>
  <brief_title>Skeletal Muscle Energetics and Fatiguability in Older Individuals</brief_title>
  <official_title>Skeletal Muscle Energetics and Fatiguability in Older Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are studying whether metabolic abnormalities in calf (leg) muscle in older&#xD;
      people with and others without HIV are associated with decreased abilities to exercise.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This research is being done to better understand why some older people living with HIV&#xD;
      experience more fatigue and difficulty exercising than older people without HIV. This is&#xD;
      important because fatigue and problems exercising are predictors of disability and&#xD;
      hospitalization in older individuals. We will use non-invasive magnetic resonance imaging&#xD;
      (MRI) and spectroscopy (MRS) of the leg muscle to measure muscle metabolites and fat content,&#xD;
      as well as blood samples measures levels of inflammation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 3, 2019</start_date>
  <completion_date type="Anticipated">July 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Maximal mitochondrial oxidative capacity (VmaxPCr)</measure>
    <time_frame>Baseline</time_frame>
    <description>Maximal oxidative capacity of leg muscle measured by 31P Magnetic Resonance Spectroscopy (MRS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of PCr decline during plantar flexion exercise</measure>
    <time_frame>Baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Six minute walk distance</measure>
    <time_frame>Baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Skeletal muscle fat content</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gait speed</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frailty status (as measured by the Fried Frailty Index)</measure>
    <time_frame>Baseline</time_frame>
    <description>Fried frailty index described in J Gerontol A bill Sci-Fi Med Sci-Fi 2001;56:M146-56</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>HIV</condition>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>HIV</arm_group_label>
    <description>Participants (ages 60 and above) with HIV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Participants (ages 60 and above) without HIV</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood Specimens&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        People with and without HIV, ages 60 and above will be enrolled&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participants who are &gt;= 60 years of age&#xD;
&#xD;
          -  HIV serostatus positive participants on stable antiretroviral therapy (ART) (no&#xD;
             regimen change in last month) with undetectable HIV viral load (&lt;100 copies).&#xD;
&#xD;
          -  HIV serostatus negative participants&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable to understand the risks, benefits, and alternatives of participation and give&#xD;
             meaningful consent&#xD;
&#xD;
          -  Contraindications to MRI&#xD;
&#xD;
          -  Significant cardiovascular, pulmonary or musculoskeletal or orthopedic disease that&#xD;
             significantly limits exercise capacity&#xD;
&#xD;
          -  Significant lower extremity peripheral vascular disease.&#xD;
&#xD;
          -  Weight greater than 350 lbs&#xD;
&#xD;
          -  Cognitive or speech impairments that would limit completion of questionnaires or&#xD;
             fatigue reporting.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert G Weiss, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Valerie Streeb, RN, BSN</last_name>
    <phone>410-955-1160</phone>
    <email>vstreeb1@jhmi.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tricia Steinberg, RN, MSN</last_name>
    <phone>443-287-3469</phone>
    <email>asteinb3@jhmi.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tricia Steinberg, MSN</last_name>
      <phone>443-287-3469</phone>
      <email>asteinb3@jhmi.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 25, 2019</study_first_submitted>
  <study_first_submitted_qc>October 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2019</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

